等待开盘 11-19 09:30:00 美东时间
-0.120
-4.08%
11月17日,Tonix Pharmaceuticals Holding Co(TNXP)收跌4.32%,报2.88美元,成交额349.43万美元,市值559...
11-17 08:19
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(2.89) per share which missed the analyst consensus estimate of $(2.31) by 25.11 percent. This is a 19.5 percent increase over losses of $(3.59) per share from the same period last year. The company reported quarterly sales of $17.200...
11-09 20:03
Tonix Pharmaceuticals reported third-quarter 2026 net sales of approximately $15 million for TONMYA, up 37% from the second quarter, with total cash and cash equivalents of $163 million as of September 30, 2026. The company highlighted strategic focus on TONMYA growth and advancing core clinical programs, including TNX-102 SL for major depressive disorder, TNX-4800 for Lyme disease prevention, and TNX-1500 for kidney transplant rejection. A confe...
11-09 12:00
Tonix Pharmaceuticals Holding Corp. announced that its management will present at Guggenheim’s 3rd Annual Healthcare Innovation Conference in Boston on November 10, 2026. The presentation, led by CEO Seth Lederman, will cover the company’s CNS disorders, infectious diseases, and immunology programs. Tonix’s flagship product, TONMYA® for fibromyalgia, and its pipeline, including TNX-102 SL for major depressive disorder and TNX-4800 for Lyme diseas...
11-04 12:00
11月3日,Tonix Pharmaceuticals Holding Co(TNXP)收涨0.98%,报5.15美元,成交额319.12万美元,市值8832...
11-03 08:04
今日重点评级关注:Stifel:维持ORIC Pharmaceuticals"买入"评级,目标价从14美元升至18美元;花旗:维持Liberty Energy"买入"评级,目标价从27.5美元升至28美元
10-27 12:30
Canaccord Genuity analyst Gary Nachman initiates coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy rating and announces Price Target of $18.
10-26 20:18
Tonix Pharmaceuticals Holding Corp. will host a conference call and webcast on November 9, 2026, at 8:30 a.m. ET to discuss third quarter 2026 financial results and operational highlights. Registration links for the call and webcast are provided. Tonix, a biopharmaceutical company, focuses on CNS disorders, infectious diseases, and immunology. Its flagship product, TONMYA®, is the first treatment for fibromyalgia in over 15 years. The company is ...
10-26 11:00
10月24日,Tonix Pharmaceuticals Holding Co(TNXP)收涨0.78%,报5.17美元,成交额385.26万美元,市值886...
10-24 07:09
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:06